BARCLAY ALEC (See Remarks) sold 11.1% of their position (5.81K shares) of T2 BIOSYSTEMS, INC. on the open market
Open‑market sale worth $4.8K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/25/2020ACC: 0000899243-20-005808
Officer· See Remarks
Since Jul 2018
+14.19K
Net shares
Net buyer
$4.8K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
20K acquired · 5.81K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+10K
Price / share
—
Trade value
—
% of position
23.8%
2/21/2020
42.10K→52.10K
Common Stock
Direct
Shares
−5.81K
Price / share
$0.82
Trade value
$4.76K
% of position
11.1%
2/24/2020
52.10K→46.29K
Total
Net shares
+4.19K
Net value
-$4.76K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/21/2020 | M · Option Exercise | +10K | — | — | 23.8% | 42.10K | 52.10K |
| Common Stock Direct | 2/24/2020 | S · Sale | −5.81K | $0.82 | $4.76K | 11.1% | 52.10K | 46.29K |
| Total | +4.19K | -$4.76K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
10K shares
Shares
+10K
Strike price
Held after
20K
Exercisable
—
2/21/2020
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock10K shares | 2/21/2020 | M · Option Exercise | +10K | — | 20K |